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Myosin regulatory light chain
Polarized ﬂuorescence
Regulatory light chain phosphorylationThe effect of phosphorylation on the conformation of the regulatory light chain (cRLC) region of myosin in ven-
tricular trabeculae from rat heart was determined by polarized ﬂuorescence from thiophosphorylated cRLCs la-
belled with bifunctional sulforhodamine (BSR). Less than 5% of cRLCs were endogenously phosphorylated in this
preparation, and similarly low values of basal cRLC phosphorylationweremeasured in fresh intact ventricle from
both rat and mouse hearts. BSR-labelled cRLCs were thiophosphorylated by a recombinant fragment of human
cardiac myosin light chain kinase, which was shown to phosphorylate cRLCs speciﬁcally at serine 15 in a
calcium- and calmodulin-dependent manner, both in vitro and in situ. The BSR-cRLCs were exchanged into
demembranated trabeculae, and polarizedﬂuorescence intensitiesmeasured for each BSR-cRLC in relaxation, ac-
tive isometric contraction and rigorwere combinedwith RLC crystal structures to calculate the orientation distri-
bution of the C-lobe of the cRLC in each state. Only two of the four C-lobe orientation populations seen during
relaxation and active isometric contraction in the unphosphorylated state were present after cRLC phosphoryla-
tion. Thus cRLC phosphorylation alters the equilibrium between deﬁned conformations of the cRLC regions of the
myosin heads, rather than simply disordering the heads as assumed previously. cRLC phosphorylation also
changes the orientation of the cRLC C-lobe in rigor conditions, showing that the orientation of this part of themy-
osin head is determined by its interaction with the thick ﬁlament evenwhen the head is strongly bound to actin.
These results suggest that cRLC phosphorylation controls the contractility of the heart by modulating the inter-
action of the cRLC region of the myosin heads with the thick ﬁlament backbone.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Contraction of both heart and skeletal muscle is driven by cyclic in-
teractions between myosin and actin [1,2]. In each cycle, the light-
chain domain (LCD) of the myosin head ampliﬁes small conformational
changes induced by the release of ATP hydrolysis products from its
catalytic domain to produce large rotational motions of the LCD. One
function of the LCD is thus to act as a ‘lever arm’ to generate nm-scale
sliding between the myosin-containing thick ﬁlaments and the actin-
containing thin ﬁlaments [3,4]. The part of the LCD next to the myosin
head-rod junction is formed by the cardiac regulatory light chain
(cRLC) winding around a short α-helix of the myosin heavy chain [5]
(Fig. 1). The cRLC is thought to be partly phosphorylated in vivo under
resting conditions, and some studies suggest that its phosphorylation
level depends on the physiological state of the myocardium, implyingR, bifunctional sulforhodamine;
diac myosin light chain kinase;
, light chain domain of myosin;
mpourakis).
. This is an open access article undera role for cRLC phosphorylation in the regulation of cardiac contractility
[6–9]. Reported values of basal cRLC phosphorylation differ substantially
however [10–12], and their interpretation is complicated by heterogene-
ity between different parts of the myocardium [7,13,14]. At a functional
level, a signiﬁcant role for cRLC phosphorylation is indicated by the effects
of hypertrophic cardiomyopathy (HCM) mutations that abolish cRLC
phosphorylation in vitro [15], and the severe cardiac dysfunction in trans-
genic mouse models expressing non-phosphorylatable cRLCs [12,16].
cRLC is phosphorylated by a cardiac-speciﬁc isoform of myosin light
chain kinase (cMLCK) [17,18], and ablation of cMLCK expression is
associated with a decrease in cRLC phosphorylation level in transgenic
mice under basal conditions, leading to an impaired beta-adrenergic re-
sponse and ventricular hypertrophy [19]. cMLCK activity has also been as-
sociated with control of sarcomere organisation in isolated mammalian
cardiomyocytes [20] and with cardiac development in a zebraﬁsh model
[17]. However, themolecularmechanisms of these effects remain elusive.
The effects of cRLC phosphorylation on themechanical properties of
the myocardium have been extensively studied. Increased cRLC phos-
phorylation has been associated with an increase in calcium sensitivity
[21], and in the rate of stretch activation [22] and cross-bridge cycling
[23] in demembranated cardiac muscle preparations. The changes inthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Bifunctional rhodamine probes on the cRLC. The regulatory light chains (blue) are
shown bound to the myosin heavy chain (green) in the atomic model for those regions
of myosin in isolated thick ﬁlaments from invertebrate muscle (PDB 3DTP). The so-called
‘blocked’ and ‘free’ heads are shown in dark and light green, respectively. The essential
light chains were removed for clarity. The model was built by superimposing the RLC
structure of the nucleotide-free scallop myosin S1 (PDB 1SR6) onto the RLC of the free
head, and by superimposing the RLC N- and C-lobes separately for the blocked head. The
N-terminal extension of the RLCwas built in Pymol using the sequence of human ventric-
ular RLC. The phosphorylatable serine 15 is shown in Van der Waals representation. BSR
probes were introduced on the RLC N-terminus (magenta), and helices E (yellow), F
(brown), and G (red) and crosslinking helices F and G (grey) in the C-terminal lobe. The
Cβ-atoms (or Cα-atoms in case of glycine residues) of mutated residues are shown as
coloured spheres and the expected probe dipole orientations are indicated by sticks. The
atomic structure of BSR (purple) is shown to scale in the right lower corner with the ori-
entation of the ﬂuorescence dipole indicated by a red double arrow.
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situ cRLC phosphorylation indicate a transfer of myosin heads towards
the thin ﬁlaments [23], suggesting that these mechanical effects may
bemediated by an increased probability of actin attachment (for review
see [11]). Electron microscopy studies of isolated thick ﬁlaments from
mammalian and invertebrate skeletal muscles [24,25] showed that the
helically ordered organisation of myosin heads on the thick ﬁlament
surface in the unphosphorylated state is lost on incubation with active
MLCK. However themolecularmechanismbywhich cRLC phosphoryla-
tion controls the conformation of the myosin heads is unknown.
We recently described a newmethod to determine the orientation of
the cRLC region of themyosin heads with respect to the ﬁlament axis in
demembranated ventricular trabeculae, based on measuring polarized
ﬂuorescence intensities from bifunctional sulforhodamine (BSR) probes
on the cRLC [26]. We showed that, in the unphosphorylated state, cRLC
orientation did not change signiﬁcantly during calcium activation, and
that its N-lobe did not change orientation even during strong attach-
ment of myosin heads to actin in rigor. These results suggested that
the cRLC interacts with the thick ﬁlament backbone via its N-lobe.
Since the N-lobe contains the phosphorylation site, modulation of this
interaction by cRLC phosphorylation might provide a mechanism for the
control of myosin head conformation. Here we tested that hypothesis
using a recombinant C-terminal fragment of the human cardiac isoform
of MLCK to thiophosphorylate BSR-labelled human cRLCs in vitro. The
BSR-cRLCswere exchanged intodemembranated right ventricular trabec-
ulae with a very low endogenous cRLC phosphorylation background, andthe orientation of thephosphorylated cRLCC-lobewas determinedduring
relaxation, active isometric contraction and rigor. An important advan-
tage of this in vitro labelling/cRLC exchange approach is that the orienta-
tion of the phosphorylated cRLCs can be determined directly in the
presence of a mixed phosphorylated/unphosphorylated population,
since only the phosphorylated cRLCs carry the probe. Comparison with
our previous results for unphosphorylated BSR-cRLCs using the same
cRLC exchange protocol [26] then allowed us to determine the change
in the in situ orientation of the C-lobe produced by cRLC phosphorylation
in each state.
2. Materials and methods
Details of protein production, preparation of cardiac trabeculae, pro-
tein exchange protocols, ﬂuorescence polarization experiments and tis-
sue sampling procedures are provided in the supplemental materials.
3. Results
3.1. Preparative thiophosphorylation of BSR-cRLCs by cMLCK
A fragment of the human cardiac isoform of myosin light chain ki-
nase (cMLCK, UniProtKB entry: Q32MK0) spanning the catalytic and
regulatory domains was expressed in and puriﬁed from Sf9 cells to
over 95% homogeneity as described in the Materials and methods sec-
tion. The puriﬁed cMLCK fragment was partially phosphorylated (34%
unphosphorylated, 55% mono- and 11% bis-phosphorylated as deter-
mined by Phostag™-SDS-PAGE; data not shown) and the phosphate
groups were removed by Lambda Protein phosphatase treatment.
There was no signiﬁcant difference between the catalytic activities of
the untreated and dephosphorylated cMLCK fragments.
Previous studies have led to contradictory conclusions about the
calcium- and calmodulin-dependence of cMLCK activity [17,18]. In the
present work, in vitro kinase assays at different enzyme-to-substrate
ratios in the presence and absence of Ca2+, calmodulin and EGTA re-
vealed a strong dependence of cMLCK activity on Ca2+ and calmodulin
(Fig. 2A), as expected from the canonical C-terminal calmodulin binding
site of cMLCK. However, some calcium-independent catalytic activity
was observed at high enzyme-to-substrate ratios.
Multiple phospho-species of cRLC have been identiﬁed in rodent
cardiac muscle [27], and human cRLC contains several residues that
could serve as potential substrates for protein kinases. Two serines in
the N-terminal extension (S15 and S19) of cRLC and a tyrosine (Y118)
in its C-lobe have been identiﬁed by mass spectrometry and site-speciﬁc
methods as potentially phosphorylated in vivo (PhosphoSitePlus®,
www.phosphosite.org) [28]. To unambiguously identify which residue
is phosphorylated by the puriﬁed cMLCK (and to exclude the possible
contribution of any co-puriﬁed kinases)wemutated the two serine res-
idues (S15 and S19) in the N-terminal extension separately or together
to alanines. The human wildtype and mutant cRLCs were tested in
in vitro kinase assays (Fig. 2). Only the wildtype and S19A mutant
could be phosphorylated, indicating that the puriﬁed cMLCK speciﬁcally
phosphorylates serine 15 in the human cRLC N-terminal extension
(Fig. 2A). Speciﬁc mono-phosphorylation of the recombinant wildtype
cRLCwas conﬁrmed by ESI mass spectrometry. Themeasured (calculat-
ed) masses (in Da) for the cRLC before and after phosphorylation by
cMLCK were 19020.6 (19020.5) and 19101.6 (19100.5), respectively.
Additionally, although rat cRLC has an additional phosphorylatable
serine at position 14 that is replaced by asparagine in the human
cRLC sequence, we found that the recombinant cMLCK also mono-
phosphorylates rat cRLC in vitro (Fig. S1), indicating that cMLCK has a
high speciﬁcity for serine 15.
ATPγS was used to preparatively thiophosphorylate BSR-labelled
cRLCs, on the basis that thiophosphorylated proteins are expected to
be relatively resistant to dephosphorylation by any protein phospha-
tases that might be present in freshly skinned trabeculae. In this study,
Fig. 2.Human cardiac myosin light chain kinase (cMLCK) phosphorylates the human ven-
tricular cRLC at serine 15 in a calcium/calmodulin dependentmanner. (A) Kinase assays at
different cRLC to cMLCK stoichiometries in the absence or in the presence of calcium and
calmodulin analysed by urea-glycerol PAGE. Note that the cRLC is signiﬁcantly phosphor-
ylated only in the presence of calcium and calmodulin. (B) Serine to alanine mutagenesis
shows that cMLCK speciﬁcally phosphorylates serine 15 in the cRLC N-terminal extension
((−), control without cMLCK; (+), with cMLCK). (C) Bifunctional sulforhodamine la-
belled cRLCmutants were preparatively thiophosphorylated by cMLCK and the phosphor-
ylation reaction analysed by urea-glycerol PAGE. Bandswere visualized by Coomassie (top
row) or by UV illumination (bottom row).
Fig. 3. Phosphorylation level of native cRLC in rat ventricle. (A) The effect of
demembranation with Triton X-100 and BDM treatment on the cRLC phosphorylation
level of right ventricular trabeculae was assessed by Phostag™-SDS-PAGE and subsequent
Western-Blot against cRLC. No signiﬁcant cRLC phosphorylation was observed indepen-
dent of the treatment (standards: RLC, recombinant RLC; RLC-P, recombinant RLC
mono-phosphorylated with cMLCK). (B) Replacement of 2.5 mM Ca2+ with 1 mM EGTA
in the cardioplegia solution used to prepare trabeculae had no signiﬁcant effect on the
RLC phosphorylation level. (C) Lysate of whole right ventricular tissue and mixture of
right and left ventricular tissuewas probed for cRLC phosphorylation level. The phosphor-
ylation levelswere estimated by densitometric analysis in ImageJ to be 0.05±0.03mol Pi/
mol RLC and 0.03 ± 0.02 mol Pi/mol RLC (mean± SEM, n= 3) for the right ventricle and
both ventricles, respectively. (D) In-situ phosphorylation of cRLC. Skinned trabecular prep-
arationswere incubatedwith cMLCK, sampleswere taken at the indicated time points and
the extent of RLC phosphorylation measured by Phostag™ SDS-PAGE andWestern blot.
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used (Fig. 1), because labelling of helices in the N-terminal lobe (partic-
ularly the A- and D-helices) interfered with phosphorylation of the
cRLCs by cMLCK (Fig. S2). Surprisingly, BSR-crosslinking of cysteine
residues introduced at positions 6 and 10, relatively close to the
phosphorylatable serine residue 15, did not signiﬁcantly interfere with
the phosphorylation reaction (Fig. 2C). All cRLCs with probes attached
in the C-terminal lobe (BSR-cRLCs E, F, G and FG) were preparatively
mono-thiophosphorylated within 2 h to 4 h to over 95% homogeneity
(Fig. 2C).
3.2. Native cRLC phosphorylation level
The distribution of phosphorylated cRLC species in rat trabeculae
wasmeasured by Phostag™-SDS-PAGE [29] followed byWestern Blot
against cRLC (Fig. 3). The endogenous cRLCs in demembranated tra-
beculae were almost entirely dephosphorylated. Neither the skin-
ning procedure nor treatment of the tissue with 2,3-butanedione
monoxime (BDM) or calcium had a signiﬁcant effect on the cRLC
phosphorylation level (Figs. 3A and 3B), suggesting that the low
cRLC phosphorylation level might be endogenous to rat trabeculaeunder basal conditions. Tissue samples removed and snap-frozen
immediately (within two minutes) after sacriﬁcing the animal also
showed a homogenously low cRLC phosphorylation level in the
right and left ventricles (Fig. 3C), further supporting this conclusion.
Incubation of skinned trabeculae with 1 μM cMLCK led to almost full
phosphorylation of the endogenous cRLCs within 2 h (Fig. 3D). The
recombinant cMLCK only mono-phosphorylated the endogenous
cRLCs in situ, consistent with the in vitro phosphorylation data de-
scribed above (Fig. S1).
A similarly low endogenous cRLC phosphorylation level was ob-
served for mouse ventricular tissue (Fig. S3). Freshly prepared
whole ventricular samples and the enriched myoﬁbrillar fraction
showed a homogenously low cRLC phosphorylation level, indicating
202 T. Kampourakis, M. Irving / Journal of Molecular and Cellular Cardiology 85 (2015) 199–206that sample preparation did not affect the cRLC phosphorylation
level measurements.
3.3. Exchange of thiophosphorylated BSR-cRLCs into skinned trabeculae
Thiophosphorylated BSR-cRLCs (subsequently referred to as ‘phos-
phorylated’) were exchanged into skinned trabeculae from rat right
ventricle by bathing the trabeculae in EDTA rigor solution containing
0.5 mg/ml of the phosphorylated BSR-cRLC for 30 min at 22 °C. Subse-
quently, the trabeculae were bathed in relaxing solution containing
0.5 mg/ml cTnC and cTn for 20 min and 1 h, respectively to replace
any of these proteins lost during cRLC exchange. The extent of exchange
was estimated by SDS-PAGE followed by either Coomassie staining or
by Western Blot against cRLC (Fig. S4), which allowed separation of
the endogenous and phosphorylated BSR-labelled cRLCs. Densitometric
analysis of the Coomassie-stained gels showed that about 30% of the
endogenous cRLCs were replaced by phosphorylated BSR-cRLC-G. In
contrast, SDS-PAGE followed by Western Blot against cRLC indicated
that 18% ± 2% of the endogenous cRLCs were replaced. Similar ex-
change ratios were obtained for the other phosphorylated BSR-cRLCs
(12% ± 6%, 20%± 5% and 14%± 8% for BSR-cRLC-E, -F and -FG, respec-
tively, mean ± SD; n = 3), in approximate agreement with the ex-
change fraction of 12% for the unphosphorylated BSR-cRLCs estimated
by ﬂuorescence intensity [26]. Incorporation of phosphorylated BSR-
cRLCs had no effect on the protein stoichiometry of skinned ventricular
trabeculae (Fig. S5), but the phosphorylation levels of cTnI and cMyBP-C
decreased. In the case of cTnI this effect may be due to replacement of
endogenous phosphorylated troponin lost during the cRLC exchange
protocol with recombinant unphosphorylated troponin complex (see
Materials andMethods). The origin of the lower cMyBP-C phosphoryla-
tion observed following the cRLC exchange protocol is unknown.
Replacement of 10%–30%of the endogenous unphosphorylated cRLC
with phosphorylated BSR-cRLC had no signiﬁcant effect on maximal
force at pCa 4.5 and 2.1 μm sarcomere length; force recovery after
cRLC exchange of un- and phosphorylated BSR-cRLCs was 88% ± 11%
(mean±SD; n=25) and 88%±9% (mean±SD; n=23), respectively.
3.4. Polarized ﬂuorescence from phosphorylated BSR-cRLCs
The polarized ﬂuorescence intensities obtained from the BSR probes
on theN-terminus, on the E, F, G helices and crosslinking the F andGhe-
lices (subsequently referred to as FG) of the phosphorylated cRLCs
(Fig. 1) were used to calculate the order parameters bP2dN, which de-
scribes the amplitude of the independent motion (“wobble”) of the
probe on the surface of the cRLC on the sub-nanosecond timescale,
and bP2N and bP4N, which describe the time-averaged orientation of
the probe ﬂuorescence dipoles with respect to the ﬁlament axis [30].
bP2dN can take values between 0 and 1, these extreme values indicating
isotropic motion on the ﬂuorescence timescale or total immobilization
of the probe on the surface of the protein, respectively. Since BSR la-
belled cRLCs were mono-phosphorylated to homogeneity in vitro, mea-
sured order parameters are exclusively frommyosin heads carrying the
phosphorylated BSR-cRLCs.
bP2dN for all probes except FG changed signiﬁcantly upon phosphor-
ylation (Fig. S6). bP2dN for the N-, E- and G-helix probes increased from
about 0.6 to about 0.75, indicating less mobility of these probes on the
sub-nanosecond timescale. In contrast, bP2dN for the F-helix probe de-
creased on phosphorylation, from around 0.9 to 0.75. These changes in
bP2dN on phosphorylation are much larger than those associated with
calciumactivation or binding ofmyosin heads to actin in rigor. The latter
interventions did not produce signiﬁcant changes in bP2dN for probes on
either the C- or N-lobe of cRLC [26], and similar results were reported
previously for probes on theN- and C-lobes of the RLC in skeletalmuscle
[31,32]. The large changes in bP2dN for the N, E, F and G helix probes on
phosphorylation suggest that the local environment of these probes has
been substantially altered. This might be due to an intermolecularinteraction between the probe and another thick ﬁlament component,
or between the N-terminal extension and the C-lobe of the cRLC (see
Discussion).
To describe the time-averaged orientation of the probes in a more
physically meaningful manner, we calculated the peak angle θME and
standard deviation σME of the probe orientation distributions with
respect to the trabecular axis from the measured order parameters
bP2N and bP4N using a maximum entropy formalism (Fig. S6). The
BSR probe attached to the cRLC N-terminal extension (BSR-cRLC-N)
showed the same peak angle under all experimental conditions, in-
dependent of phosphorylation. For BSR-cRLC-E and -F, phosphoryla-
tion increased the peak angle θME during relaxation towards the
value measured during active isometric contraction in the dephos-
phorylated state, but did not change θME signiﬁcantly during active
isometric contraction and rigor. σME decreased for BSR-cRLC-E in re-
laxation and active contraction, but increased for BSR-cRLC-F in all
three states. The largest changes in the angular distribution were ob-
served for BSR-cRLC-G, with an increase in θME under all experimen-
tal conditions. Phosphorylation did not signiﬁcantly change the
angular distribution of BSR probes crosslinking helices F and G. The
implications of these changes are best understood by combining
the results from the different probes to calculate the overall orienta-
tion of the cRLC C-lobe in each state, as described below.
3.5. Orientation of the phosphorylated cRLCC-lobe in ventricular trabeculae
The orientation of the cRLC C-lobewas described in terms of its local
EG-helix frame (see Materials and Methods section), with β describing
the angle between the E-helix and the ﬁlament axis, and γ describing
rotation of the C-lobe around the E-helix. We showed previously that
the orientation distribution of the unphosphorylated cRLC C-lobe in re-
laxation and active contraction (Fig. 4A) can be described in terms of
four populations, referred to as C1 to C4 in order of increasing β [26].
There is very little change in the unphosphorylated cRLC C-lobe orienta-
tion distribution on calcium activation, but the C1 and C3 peaks become
much weaker in rigor. An analogous study of the unphosphorylated
cRLC N-lobe showed similar orientation distributions in relaxation,
active isometric contraction and rigor [26], suggesting that the cRLC re-
gion of myosin might stays docked onto the thick ﬁlament backbone
through interactions with the cRLC N-lobe in all these states when the
cRLC is unphosphorylated.
When the cRLC is phosphorylated (Fig. 4B), the orientation distri-
butions of the C-lobe of the cRLC in relaxation and isometric contrac-
tion show two main peaks, corresponding to the C2 and C3 peaks
seen for the unphosphorylated cRLC, with (βEG, γEG) = (60°,
−60°) and (85°, 35°), respectively. Phosphorylated cRLC C-lobes
are less likely to be in the more parallel orientations C1 and C4,
with (βEG, γEG) = (30°, 15°) and (125°,−30°), respectively. Qualita-
tively similar effects of phosphorylation on cRLC C-lobe orientation
were observed when different cRLC reference structures were used
for the ME calculations (Fig. S7). Thus the conclusions about the ef-
fects of cRLC phosphorylation on its orientation are unlikely to be in-
ﬂuenced by a change in the overall fold of the light chain domain,
which is almost unaffected by phosphorylation in vitro [33]. The ori-
entation distributions in Fig. 4 were also not signiﬁcantly affected by
the experimental variability in the order parameters bP2N and bP4N
(Tab. S1), as shown by repeating the ME calculations with values
chosen at random from normal distributions of the measured order
parameters (Fig. S8).
As noted previously [26], peak C4 of the cRLC C-lobe orientation dis-
tribution, which is more prominent in the unphosphorylated state
(Fig. 4A), is close to the orientations of the RLC C-lobe in the myosin
heads in isolated thick ﬁlaments from invertebrate skeletal muscle
(Fig. 1) [34]. In this asymmetric structure, sometimes called the
‘J-motif ’ or ‘interacting heads motif’, which seems to be conserved
among muscle types and species [35,36], the myosin heads are folded
Fig. 4. Orientation distributions of the cRLC C-lobe in ventricular trabeculae during relaxation (RELAX), active isometric contraction (ACTIVE) and rigor calculated from the order param-
etersmeasured from unphosphorylated (A) and phosphorylated BSR-cRLCs (B), using the structure of scallopmyosin S1 in the nucleotide-free state (PDB entry 1SR6). The calculated cRLC
C-lobe orientations (β,γ) for the blockedand free heads (PDBentry 3DTP), and ‘phos-free-like’ and ‘phos-blocked-like’ (PDB entry3J04) aligned by their S2 regions are indicated by red and
white, and brown and light orange diamonds, respectively. The calculated orientations for nucleotide-free chicken skeletal S1 (PDB entry 2MYS) and scallop S1 (PDB entry 1SR6), ADP-
bound squid S1 (PDB entry 3I5F), pre-power-stroke scallop S1 (PDB entry 1QVI), and smooth muscle S1 in the ADP.Pi state (1BR1), with their catalytic domains superimposed onto
the nucleotide-free chicken skeletal myosin S1 in the actin-S1 rigor complex, are shown as orange, yellow, cyan, green and pink diamonds respectively.
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‘blocked’ and ‘free’ heads of the J-motif are indicated by red and white
diamonds in Fig. 4A. The weakening of the C4 peak on cRLC phosphor-
ylation (Fig. 4B) therefore suggests that the J-motif is disrupted by
cRLC phosphorylation. The more perpendicular C2 and C3 orientations
that dominate the orientation maps for phosphorylated cRLC are more
similar to those observed in 2D crystals of isolated phosphorylated
HMM from smooth muscle [37] (PDB entry 3J04). These are shown as
the brown and orange diamonds in Fig. 4B, for the so-called phospho-
free-like and phospho-blocked-like heads respectively. Although these
orientations are roughly perpendicular to the ﬁlament axis, like the C2
and C3 peaks, they have a different twist angle γ.
The orientation of the C-lobe of phosphorylated cRLC did not
change signiﬁcantly during the transition from relaxation to active
isometric contraction (Fig. 4B). Thus the C-lobe orientation is almost
insensitive to calcium activation, as reported previously for the
unphosphorylated cRLC (Fig. 4A) [26]. Peaks C2 and C3 for phosphor-
ylated cRLC remained strong in rigor (Fig. 4B), but C4 was stronger
than in relaxation or active contraction. The rigor orientation distri-
bution depends strongly on cRLC phosphorylation, with C4 much
weaker but C3 much stronger in the phosphorylated state (compare
Fig. 4B with Fig. 4A). Since all myosin heads are thought to be strong-
ly bound to actin in rigor, these cRLC C-lobe orientations can be com-
pared with those expected when the catalytic domains of published
myosin head or S1 structures are docked onto that of the canonical
actin-S1 rigor complex [38]. The resulting C-lobe orientations for
nucleotide-free S1s from chicken and scallop muscle, shown as the
orange and yellow diamonds in Fig. 4 (Rigor), are close but not iden-
tical to peak C4. Squid S1 with bound ADP (cyan) is close to the
symmetry-related equivalent of C2, scallop muscle S1 in the pre-
power-stroke state (green) is close to C3, and chicken smooth
muscle S1 in the pre-power-stroke state (pink) is close to C1 respec-
tively. These comparisons emphasize the diversity of relativeorientations of the light-chain and catalytic domains in published
S1 crystal structures, a diversity that is matched by that of the cRLC
C-lobe orientations in cardiac muscle cells.
4. Discussion
4.1. Phosphorylation level of endogenous ventricular myosin regulatory
light chain
As noted in the Introduction, there is no clear consensus about the
basal level of cRLC phosphorylation in mammalian cardiac muscle.
Some studies have reported a constant level of 0.4–0.5 mol Pi/mol
cRLC [39] (for review see [11]), whereas others have reported much
lower ventricular RLC phosphorylation levels [6,12,40]. These differ-
ences may be associated with heterogeneity between different parts
of the heart [7,13,41] and potential effects of species, gender and tissue
sampling procedures [42].
The cardiac muscle preparations from rat ventricle used in the pres-
ent experiments had a consistently low cRLC phosphorylation level of
less than 0.05 mol Pi/mol cRLC, and this was independent of the tissue
treatment. Moreover the same low level was measured in the intact
ventricle immediately snap-frozen after excision (Fig. 3). Freshly pre-
pared mouse heart myoﬁbrils and whole ventricular preparations that
were immediately snap-frozen after excision of the heart showed that
the mouse cRLCs are also almost entirely unphosphorylated (Fig. S3)
suggesting that the low ventricular cRLC phosphorylation level is con-
served among rodent species and independent of the sample prepara-
tion. Similar low cRLC phosphorylation levels were recently measured
in swine myocardium by mass spectrometry [10], suggesting that the
basal phosphorylation level of mammalian cRLCs might be lower or
more dynamic than previously thought.
An increase in cRLC phosphorylation level in intact cardiac muscle
has been associated with an increase in the stimulation frequency,
Fig. 5. Schematicmodel for the effect of cRLC phosphorylation onmyosin head orientation.
(A) Unphosphorylated myosin heads are in a conformational equilibrium between more
parallel ‘ON’-states (peaks C1 and C4, Fig. 4) and more perpendicular ‘OFF’-states (peaks
C2 and C3), controlled by the interaction of the cRLC with the thick ﬁlament surface. The
cRLC and ELC are shown in blue and orange, respectively. The N- and C-terminal lobes of
the cRLC are labelled accordingly. (B) Phosphorylation of cRLC destabilizes the parallel
‘OFF’-conformations (C1 and C4) promoting attachment of the catalytic domain of myosin
to actin.
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these stimuli work upstream of cRLC phosphorylation and might be in-
volved in the activation of cardiac myosin light chain kinase (cMLCK).
Prolonged incubation of skinned cardiac muscle preparations with re-
combinant cMLCK led to almost full phosphorylation of the endogenous
cRLCs in our preparations, suggesting that both cRLCs of the double-
headed myosin molecule are available for phosphorylation by cMLCK
in situ. However, the cMLCK phosphorylated the cRLCs to a maximum
level of ca 1 mol/mol both in situ and in vitro, suggesting that different
signalling pathways are involved in the multiple phosphorylated cRLC
species identiﬁed in rodent cardiac muscle in vivo [43–45].
4.2. Effects of phosphorylation on cRLC dynamics
Phosphorylation of the cRLC produced signiﬁcant changes in the
order parameter bP2dN for the BSR probes (Table S1), which describes
the amplitude of fast probe motion (“wobble”) on the surface of the
cRLC. The observed changes were much larger than those associated
with the transition from relaxation to active isometric contraction or
rigor, suggesting that cRLC phosphorylation leads to a much larger
change in the local environment of the probes. These effects were not
conﬁned to the probe close to the phosphorylatable serine 15 in the
cRLC N-terminal extension (BSR-cRLC-N), suggesting that they are due
to global changes in cRLC environment associated with changes in its
tertiary structure or with intermolecular interactions. The observation
that the crystal structure of the scallop smooth muscle light chain do-
main does not change signiﬁcantly on RLC phosphorylation [33] argues
against the former explanation.
A more likely explanation, suggested previously as a mechanism for
activation of smoothmuscle contraction by RLC phosphorylation [46], is
that interactions between the cRLC N-terminal extension and other re-
gions on the surface of the cRLC are altered by phosphorylation of serine
15. A similar mechanism was recently proposed for the effect of phos-
phorylation of serines 22/23 of cardiac troponin I, involving contacts be-
tween positively charged residues in its N-terminal extension, close to
serines 22/23, and negatively charged residues in theN-lobe of troponin
C [47].
4.3. cRLC phosphorylation controls myosin head orientation in diastole and
systole
The distribution of the orientations of phosphorylated cRLC with re-
spect to the thick ﬁlament axis in the relaxed (low calcium or diastolic)
state showed two distinct peaks (Fig. 4B), in contrast with the four
described previously for unphosphorylated cRLC (Fig 4A). The more
parallel orientations C1 and C4 become much weaker on phosphoryla-
tion, and the more perpendicular orientations, C2 and C3, dominate
the distributions in the phosphorylated state. The orientation distribu-
tion of the cRLC C-lobe is thereforemore ordered in the phosphorylated
state, in contrast with the overall distribution ofmyosin head conforma-
tions inferred from electron-microscopy studies on isolated thick
ﬁlaments from invertebrate [25,48] and vertebrate muscle [24], which
are disordered in the phosphorylated state. Thus, at the level of the
cRLC region of myosin, phosphorylation shifts the conformational equi-
librium towards perpendicular states rather than inducing disorder of
this region, although the catalytic domains of the heads may be more
orientationally disordered in the phosphorylated state.
The C4 orientation seen in the unphosphorylated state is similar to
that in the free and blocked heads of the ‘J motif’ or ‘interacting heads
motif’ conformation seen by EM of isolated ﬁlaments, in which the my-
osin heads are close to the thick ﬁlament backbone [34–36], in an ‘OFF’
or ‘super-relaxed’ state of the thick ﬁlament [49]. The C1 peak, being
even more parallel to the ﬁlament axis, might also correspond to a
folded state (Fig. 5). However it is also possible that the C1 peak, with
an orientation similar to that expected for actin-bound myosin heads
in the pre-powerstroke or transition state (pink diamond in Fig. 4A),corresponds to myosin heads that are weakly attached to actin in
relaxing or diastolic conditions.
Phosphorylation of the cRLC weakens both the C1 and C4 peaks, re-
ducing the number of myosin heads in the ‘super relaxed’ state or ‘OFF’
state of the thick ﬁlament (Fig. 5). The perpendicular C2 and C3 peaks
becomemore prominent (Fig. 4B), and this perpendicular conformation
would lead to the heads extending out from the thick ﬁlament back-
bone, bringing their motor domains closer to the thin ﬁlament and pro-
moting interaction with actin (Fig. 5). Such a motion of myosin heads
towards the thin ﬁlaments on phosphorylation is consistent with X-
ray studies on skinned cardiac muscle [23], and with the increase in
calcium sensitivity associatedwith cRLC phosphorylation [21]. A similar
mechanism has been proposed for the functional effects of RLC phos-
phorylation in the indirect ﬂight muscles of insects [50].
In contrast with the large effects of cRLC phosphorylation described
above, the orientation of the cRLC region did not change signiﬁcantly on
calcium activation in either the phosphorylated or unphosphorylated
states, suggesting that strong attachment of myosin to actin during
active contraction (in systole) does not alter the orientation of the C-
lobe of cRLC. This is consistent with our previous conclusion [26] that
the primary function of the cRLC region of myosin is to regulate the
availability of myosin heads for attachment to actin. The present results
show that this transition between the ‘OFF’ and ‘ON’ conformations of
the myosin heads is controlled by the phosphorylation state of the
cRLC (Fig. 5).
One potential limitation of the present experiments is that less than
30% of endogenous unphosphorylated rat cRLCs were replaced by phos-
phorylated BSR-RLCs, so that the majority of myosin heads in the trabec-
ulae were unphosphorylated. Although the in vitro phosphorylation and
labelling protocol used here speciﬁcally measures the orientation of the
phosphorylated cRLCs within a mixed population of phosphorylated
and unphosphorylatedmyosin heads in situ, we cannot exclude the pos-
sibility that intra- or intermolecular interactions between the heads [35,
36] might attenuate the observed effects of phosphorylation when a
low fraction of heads are phosphorylated. Such an effect would imply
that an even larger effect of cRLC phosphorylation on its orientation
distribution might be observed at higher phosphorylation levels, and
might explain the residual C1 and C4 features seen for the phosphory-
lated cRLCs in relaxation and active contraction in the present experi-
ments (Fig. 4B). However, given the very low level of basal cRLC
phosphorylation in the preparation used here, the levels of cRLC phos-
phorylation achieved here are likely to be in the physiological range.
The present results clearly establish that relatively low changes in phos-
phorylation level in this range are sufﬁcient to produce signiﬁcant
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ed thick ﬁlaments from vertebrate skeletal muscle, in which phosphor-
ylation of only 10% of the RLCs was sufﬁcient to disorder the helical
array of myosin heads [24].
4.4. Structuralmechanism for the thick ﬁlament-based regulation of cardiac
contractility by cRLC phosphorylation
Since the cRLC region of the myosin heads remains ordered after
cRLC phosphorylation (Fig. 4B), even in the calcium-activated systolic
state, the present results suggest that an interaction between the cRLC
and the thick ﬁlament backbone is maintained after cRLC phosphoryla-
tion. Thus the present results imply amodiﬁcation of themechanism by
which RLC phosphorylation controls the conformation of the myosin
heads suggestedpreviously by electronmicrographs of isolated thickﬁl-
aments from invertebrates [25,48] and vertebrates [24], and by X-ray
diffraction studies on skinned mammalian cardiac muscle [23]. Those
studies suggested that the effect of RLC phosphorylation on myosin
head conformation wasmediated by a weakening or breaking of the in-
teraction between cRLC and the ﬁlament backbone; the present results,
in contrast, suggest that the cRLC region of myosin stays bound to the
thick ﬁlament backbone in a preferred conformation. The effect of RLC
phosphorylation is to shift the conformational equilibriumbetween dis-
tinct RLC: backbone interactions that correspond to distinct RLCorienta-
tions and by implication distinct conformations of the myosin motor
domain (Fig. 5).
The effect of cRLC phosphorylation on actin-bound myosin heads
in rigor provides further support for the above conclusion. In the
unphosphorylated state, the cRLC C-lobe adopts a conformation (Fig. 4;
peak C4) similar to that of nucleotide-free scallop myosin S1 in the rigor
complex (Fig. 4; yellow diamond). After phosphorylation, however, the
predominant orientations are those populated during relaxation and ac-
tive contraction (peaks C2 and C3), and C4 becomes a minor population.
Since cRLC phosphorylation is unlikely to change the actin-interaction of
the catalytic domain in rigor, this change in cRLC orientation implies a
phosphorylation-mediated change in the preferred conformation of the
cRLC on the thick ﬁlament surface in a myosin head that is strongly
bound to actin. It follows that all or part of the cRLC is not part of the func-
tional lever arm of the myosin motor in cardiac muscle, which would
therefore be shorter thanpreviously assumed [26]. This effectmay require
an intact thick ﬁlament, since cRLC phosphorylation leads to an increase
in mean step-size in isolated cardiac myosin [51].
Control of myosin head conformation by mediating conformational
states of cRLC at its interaction point with the thick ﬁlament might rep-
resent a commonmechanism for thickﬁlament-based control of cardiac
contractility. The interactions of cRLC with the N-terminus of cMyBP-C
[52] and with the A-band region of titin [36] could also feed into this
regulatory pathway to constrain the conformational and regulatory
state of the myosin heads.
5. Conclusions
We found that the basal in vivo cRLC phosphorylation level in the ro-
dent heart is lower than previously thought, at less than 0.05mol Pi/mol
cRLC. Serine 15 of cRLC is phosphorylated by cMLCK in a calcium/
calmodulin dependent manner. cRLC phosphorylation does not disor-
der the cRLC region of the myosin heads, but alters the conformational
equilibrium towards states inwhich the heads can interactmore readily
with the thin ﬁlament. cRLC phosphorylation controls myosin head ori-
entation and the contractility of the heart by modulating interactions
between the cRLC region of myosin and the thick ﬁlament backbone.
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